Piao Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Piao Zhang has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Yuhu Zhang
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
5 shared publications Baoyu Zhu
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
3 shared publicationsJiezhu Feng
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
3 shared publications- Lijuan Wang
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
3 shared publications Xiaomei Liang
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
3 shared publicationsKaicheng Wang
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Springer Nature in npj Parkinson's Disease
Sleep deprivation exacerbates Parkinson’s disease via PPARγ–PLIN4-mediated microglial lipid droplet accumulation and neuroinflammation
- 25 August 2026
- Published by Springer Nature in npj Parkinson's Disease
Open AccessSleep deprivation exacerbates Parkinson’s disease via PPARγ–PLIN4-mediated microglial lipid droplet accumulation and neuroinflammation
- 4 October 2025
- Published by Elsevier in Neurochemistry International
- Vol. 191, 106068
TREM2 deficiency aggravates neuroinflammatory response and cognitive impairment via disease-associated microglia in Parkinson's disease models
- 4 October 2025
- Published by Elsevier in Neurochemistry International
- Vol. 191, 106068
TREM2 deficiency aggravates neuroinflammatory response and cognitive impairment via disease-associated microglia in Parkinson's disease models
- Open Access
- 20 May 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-12
TREM2 deficiency exacerbates cognitive impairment by aggravating α-Synuclein-induced lysosomal dysfunction in Parkinson’s disease
Cognitive impairment in Parkinson’s disease (PD) is a widespread and rapidly progressive feature that impacts prognosis. Although TREM2 has been implicated in neuroprotection across various neurodegenerative diseases, its specific role in PD remains to be clarified. In this study, we first detected the hippocampus of human PD specimens and of the mutant A53T α-Synuclein transgenic mice (A53T mice), and found a significant increase in the number of TREM2+ microglia. To evaluate the effects of TREM2 deficiency, TREM2-deficient A53T mice (TREM2-/-/A53T mice) were generated. In these mice, exacerbated cognitive impairment, neurodegeneration, disruption of synaptic plasticity, and accumulation of pathological α-Synuclein (α-Syn) in the hippocampus were observed, without any detected motor dysfunction. Despite increased infiltration of activated microglia surrounding α-Syn aggregates, lysosomal dysfunction in microglia was aggravated in the TREM2-/-/A53T mice. In addition, transcriptional analyses and in vitro experiments further found that TREM2 knockdown inhibited the nuclear distribution of TFEB via the ERK1/2 pathway, exacerbating α-Syn-induced lysosomal dysfunction and causing more pathological α-Syn accumulation. Finally, HT22 cells were cocultured with TREM2 knockdown of BV-2 cells pretreated with recombinant human A53T α-Syn preformed fibrils (PFFs). The coculture experiments showed that TREM2 knockdown in BV-2 cells pretreated with PFFs enhanced the phosphorylation of α-Syn and promoted apoptosis in HT22 cells via inhibiting α-Syn degradation. In conclusion, TREM2 deficiency exacerbates cognitive impairment in PD by exacerbating α-Syn-induced microglial lysosomal dysfunction, identifying TREM2 as a potential therapeutic target.
- 20 May 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-12
Open AccessTREM2 deficiency exacerbates cognitive impairment by aggravating α-Synuclein-induced lysosomal dysfunction in Parkinson’s disease
Cognitive impairment in Parkinson’s disease (PD) is a widespread and rapidly progressive feature that impacts prognosis. Although TREM2 has been implicated in neuroprotection across various neurodegenerative diseases, its specific role in PD remains to be clarified. In this study, we first detected the hippocampus of human PD specimens and of the mutant A53T α-Synuclein transgenic mice (A53T mice), and found a significant increase in the number of TREM2+ microglia. To evaluate the effects of TREM2 deficiency, TREM2-deficient A53T mice (TREM2-/-/A53T mice) were generated. In these mice, exacerbated cognitive impairment, neurodegeneration, disruption of synaptic plasticity, and accumulation of pathological α-Synuclein (α-Syn) in the hippocampus were observed, without any detected motor dysfunction. Despite increased infiltration of activated microglia surrounding α-Syn aggregates, lysosomal dysfunction in microglia was aggravated in the TREM2-/-/A53T mice. In addition, transcriptional analyses and in vitro experiments further found that TREM2 knockdown inhibited the nuclear distribution of TFEB via the ERK1/2 pathway, exacerbating α-Syn-induced lysosomal dysfunction and causing more pathological α-Syn accumulation. Finally, HT22 cells were cocultured with TREM2 knockdown of BV-2 cells pretreated with recombinant human A53T α-Syn preformed fibrils (PFFs). The coculture experiments showed that TREM2 knockdown in BV-2 cells pretreated with PFFs enhanced the phosphorylation of α-Syn and promoted apoptosis in HT22 cells via inhibiting α-Syn degradation. In conclusion, TREM2 deficiency exacerbates cognitive impairment in PD by exacerbating α-Syn-induced microglial lysosomal dysfunction, identifying TREM2 as a potential therapeutic target.
- Open Access
- 1 August 2022
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 12 (8) , 4226-4238
Metabolite changes in prefrontal lobes and the anterior cingulate cortex correlate with processing speed and executive function in Parkinson disease patients
Original Article Metabolite changes in prefrontal lobes and the anterior cingulate cortex correlate with processing speed and executive function in Parkinson disease patients Chentao He, Siming Rong, Piao Zhang, Ruitao Li, Xiaohong Li, Yan Li, Lijuan Wang, Yuhu Zhang
- 1 August 2022
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 12 (8) , 4226-4238
Open AccessMetabolite changes in prefrontal lobes and the anterior cingulate cortex correlate with processing speed and executive function in Parkinson disease patients
Original Article Metabolite changes in prefrontal lobes and the anterior cingulate cortex correlate with processing speed and executive function in Parkinson disease patients Chentao He, Siming Rong, Piao Zhang, Ruitao Li, Xiaohong Li, Yan Li, Lijuan Wang, Yuhu Zhang
- 1 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 639-643
Effect of Mo Alloying on Properties of High Manganese Steel Castings and Cost Analysis
Under the condition of high stress and high impact wear, the new anti-wear material with high toughness has high application value. In this paper, in order to improve the wear resistance of high manganese steel to better meet the service conditions, and to reduce the cost of materials. The effect of molybdenum alloying on the structure and mechanical properties of high manganese steel was studied. Combined with numerical simulation, the filling, solidification temperature change and shrinkage cavity defects of the casting were analyzed. The simulation results are in good agreement with the actual production castings, and the casting quality is improved. The test results show that the mechanical properties of alloyed high manganese steel castings are better than those of high manganese steel castings. The tensile strength, hardness and impact toughness of high manganese steel castings are increased by 13.06%, 49.41% and 44.7% respectively. Mo element can significantly better the mechanical property, the microstructure, the shape of the steel. According to the experimental results and material cost analysis, the cost variation trend of high manganese steel can be predicted while improving its performance.
- 1 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 639-643
Effect of Mo Alloying on Properties of High Manganese Steel Castings and Cost Analysis
Under the condition of high stress and high impact wear, the new anti-wear material with high toughness has high application value. In this paper, in order to improve the wear resistance of high manganese steel to better meet the service conditions, and to reduce the cost of materials. The effect of molybdenum alloying on the structure and mechanical properties of high manganese steel was studied. Combined with numerical simulation, the filling, solidification temperature change and shrinkage cavity defects of the casting were analyzed. The simulation results are in good agreement with the actual production castings, and the casting quality is improved. The test results show that the mechanical properties of alloyed high manganese steel castings are better than those of high manganese steel castings. The tensile strength, hardness and impact toughness of high manganese steel castings are increased by 13.06%, 49.41% and 44.7% respectively. Mo element can significantly better the mechanical property, the microstructure, the shape of the steel. According to the experimental results and material cost analysis, the cost variation trend of high manganese steel can be predicted while improving its performance.
- Open Access
- 1 June 2021
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1948 (1) , 012204
Microstructure and wear properties of high manganese steel by V-Ti alloying elements
High manganese steel was prepared by adjusting the components of the alloys by adding V-Ti. The investigation was carried out to study the effect of V-Ti elements alloying on the microstructure and wear properties of high manganese steel through metallographic microscope, scanning electron microscopy, mechanical machine and abrasive wear tests. The test results showed that V-Ti alloying improved the properties of high manganese steel. The grains are refined, size of impurities are reduced, the form and distribution of impurities are also ameliorated. In addition, the hardness was increased by 23.7%~84.6% and tensile strength can be increased up to 31.3%.
- 1 June 2021
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1948 (1) , 012204
Open AccessMicrostructure and wear properties of high manganese steel by V-Ti alloying elements
High manganese steel was prepared by adjusting the components of the alloys by adding V-Ti. The investigation was carried out to study the effect of V-Ti elements alloying on the microstructure and wear properties of high manganese steel through metallographic microscope, scanning electron microscopy, mechanical machine and abrasive wear tests. The test results showed that V-Ti alloying improved the properties of high manganese steel. The grains are refined, size of impurities are reduced, the form and distribution of impurities are also ameliorated. In addition, the hardness was increased by 23.7%~84.6% and tensile strength can be increased up to 31.3%.
- Open Access
- 27 December 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 221
Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review
Dopamine agonists (DAs) are efficacious for the treatment of motor and nonmotor symptoms in patients with Parkinson’s disease (PD). The treatment of PD with DAs is often complicated by adverse drug reactions (ADRs) of dopaminergic and non-dopaminergic origins. The DA piribedil is widely used in Asian, European, and Latin American countries; therefore, its ADRs are pertinent to clinicians. Here we present a rare case of hypotension and bradycardia that is significantly related to the dosage of piribedil. A middle-aged male, diagnosed with PD, received dopamine replacement with piribedil. When taking 50 mg piribedil daily dose, the patient didn’t feel any discomfort. Two hours after taking 100 mg piribedil he presented with serious concomitant hypotension and bradycardia with a blood pressure (BP) reading of 85/48 mmHg and a heart rate (HR) of 45 beats/min when sitting. After taking 75 mg piribedil, the patient showed the same symptoms with BP reading at 70/45 mmHg and HR of 47 beats/min in the same position. Upon replacing treatment with pramipexole 0.125 mg, 0.25 mg, and 0.375 mg three times a day, no further cardiovascular effects persisted. No studies have previously reported the simultaneous observation of position-unrelated hypotension and bradycardia after taking small doses of piribedil. More studies are needed to explore the effects of DAs on BP and HR, especially piribedil. Piribedil is efficacious for the treatment of PD, but it is important to weigh the potential risk of hypotension and bradycardia against the clinical benefits of this drug.
- 27 December 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 221
Open AccessHypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review
Dopamine agonists (DAs) are efficacious for the treatment of motor and nonmotor symptoms in patients with Parkinson’s disease (PD). The treatment of PD with DAs is often complicated by adverse drug reactions (ADRs) of dopaminergic and non-dopaminergic origins. The DA piribedil is widely used in Asian, European, and Latin American countries; therefore, its ADRs are pertinent to clinicians. Here we present a rare case of hypotension and bradycardia that is significantly related to the dosage of piribedil. A middle-aged male, diagnosed with PD, received dopamine replacement with piribedil. When taking 50 mg piribedil daily dose, the patient didn’t feel any discomfort. Two hours after taking 100 mg piribedil he presented with serious concomitant hypotension and bradycardia with a blood pressure (BP) reading of 85/48 mmHg and a heart rate (HR) of 45 beats/min when sitting. After taking 75 mg piribedil, the patient showed the same symptoms with BP reading at 70/45 mmHg and HR of 47 beats/min in the same position. Upon replacing treatment with pramipexole 0.125 mg, 0.25 mg, and 0.375 mg three times a day, no further cardiovascular effects persisted. No studies have previously reported the simultaneous observation of position-unrelated hypotension and bradycardia after taking small doses of piribedil. More studies are needed to explore the effects of DAs on BP and HR, especially piribedil. Piribedil is efficacious for the treatment of PD, but it is important to weigh the potential risk of hypotension and bradycardia against the clinical benefits of this drug.
- Open Access
- 19 July 2017
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 11, 213
Transplantation of Hematopoietic Stem Cells Promotes Functional Improvement Associated with NT-3-MEK-1 Activation in Spinal Cord-Transected Rats
To investigate the effects of hematopoietic stem cells (HSCs) on the recovery of structure and function in the spinal cord transected (SCT) rats and explore associated mechanisms, 57 adult Sprague–Dawley rats were randomly divided into sham (n=15), SCT (n=24), and HSC transplantation groups (n=15). HSCs (passage 3) labeled by Hoechst 33342, were then transplanted intraspinally into the rostral, scar and caudal sites of the transected lesion at 14 days post operation. Both in vitro and vivo, HSCs exhibited the capacity of proliferation and differentiation. Following HSCs transplantation, BBB scores picked up significantly from week 4 to 24 after SCT, which was corresponding to the increased number of 5-HT fibers and oligodendrocytes , while the number of astrogliosis was decreased markedly indicated by immunohistochemical staining. Moreover, the decreased expression of neurotrophin 3 (NT3) and MEK-1 after SCT was effectively restored by HSCs transplantation. Together, the current study revealed that intraspinally administered HSCs in the chronic phase of SCT benefits the improvement of neurological function and the underlying mechanisms involved in the enhancement of 5-HT positive fibers and oligogenesis, and suppression of excessive astrogliosis, together with the upregulation of NT3-regulated MEK-1 activation in spinal cord. These crucial findings revealed not only the mechanism of cell therapy, but also may contribute to a novel therapeutic target for the treatment of SCI.
- 19 July 2017
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 11, 213
Open AccessTransplantation of Hematopoietic Stem Cells Promotes Functional Improvement Associated with NT-3-MEK-1 Activation in Spinal Cord-Transected Rats
To investigate the effects of hematopoietic stem cells (HSCs) on the recovery of structure and function in the spinal cord transected (SCT) rats and explore associated mechanisms, 57 adult Sprague–Dawley rats were randomly divided into sham (n=15), SCT (n=24), and HSC transplantation groups (n=15). HSCs (passage 3) labeled by Hoechst 33342, were then transplanted intraspinally into the rostral, scar and caudal sites of the transected lesion at 14 days post operation. Both in vitro and vivo, HSCs exhibited the capacity of proliferation and differentiation. Following HSCs transplantation, BBB scores picked up significantly from week 4 to 24 after SCT, which was corresponding to the increased number of 5-HT fibers and oligodendrocytes , while the number of astrogliosis was decreased markedly indicated by immunohistochemical staining. Moreover, the decreased expression of neurotrophin 3 (NT3) and MEK-1 after SCT was effectively restored by HSCs transplantation. Together, the current study revealed that intraspinally administered HSCs in the chronic phase of SCT benefits the improvement of neurological function and the underlying mechanisms involved in the enhancement of 5-HT positive fibers and oligogenesis, and suppression of excessive astrogliosis, together with the upregulation of NT3-regulated MEK-1 activation in spinal cord. These crucial findings revealed not only the mechanism of cell therapy, but also may contribute to a novel therapeutic target for the treatment of SCI.
- Open Access
- 1 December 2016
- Published by Elsevier in International Journal of Electrochemical Science
- Vol. 11 (12) , 10763-10778
Durability and Activity Tunable Pt/Graphene Catalyst for Oxygen Reduction Reactions
- 1 December 2016
- Published by Elsevier in International Journal of Electrochemical Science
- Vol. 11 (12) , 10763-10778
Open AccessDurability and Activity Tunable Pt/Graphene Catalyst for Oxygen Reduction Reactions